| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | WDR5-IN-7 Basic information |
| Product Name: | WDR5-IN-7 | | Synonyms: | WDR5-IN-7;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-7-(1H-imidazol-1-ylmethyl)-9-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-4-[(5S)-5,6,7,8-tetrahydro-3-methoxy-5-quinolinyl]- | | CAS: | 3032761-31-9 | | MF: | C28H27F3N6O3 | | MW: | 552.55 | | EINECS: | | | Product Categories: | | | Mol File: | 3032761-31-9.mol |  |
| | WDR5-IN-7 Chemical Properties |
| Boiling point | 776.235±60.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.452±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) |
| | WDR5-IN-7 Usage And Synthesis |
| Uses | WDR5-IN-7 (Compound 22) is an orally bioavailable benzoxazepinone-based WD repeat domain 5 (WDR5) inhibitor. WDR5-IN-7 can be used for the research of anti-cancer[1]. | | References | [1] Teuscher KB, et al. Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors. J Med Chem. 2023 Dec 12. DOI:10.1021/acs.jmedchem.3c01529 |
| | WDR5-IN-7 Preparation Products And Raw materials |
|